Molecularly, hyaluronic acid binds to different membrane receptors including the glycoprotein receptor CD44 and the receptor for hyaluronan-mediated motility (RHAMM), which has a central role in glioma cell motility, invasion, and inflammation (19, 213). The gene discussed is CD44; the disease is glioma.